-
Although aspirin (ASA), particularly low-dose ASA 81 mg/d (LD-ASA), is well established as an appropriate agent for secondary prevention of cardiovascular disease, recent results from the Women's Health Study (WHS) about the impact of ASA in primary prevention came as a surprise...
-
-
This report begins with discussion of the most superficial lesions and progresses through the skin and soft tissue to the deeper and systemic disease processes.
-
A return to full normal activities, including work at 2 weeks, after AMI appears to be safe in patients who are stratified to a low-risk group.
-
The number of previous acute exacerbations of chronic bronchitis (AECBs) and the baseline FEV1 level are potent prognostic factors of the short- and long-term outcomes of AECB.
-
Itopride, a D2 dopamine agonist with anticholinesterase effects, was marginally superior to placebo in 'functional dyspepsia.'
-
Visual hallucinations, extrapyramidal motor signs, and visuoconstructional impairments at time of presentation are strongly suggestive of a diagnosis of dementia with Lewy bodies.
-
A novel T-cell inhibitor has been approved for the treatment of rheumatoid arthritis. Abatacept is the first selective modulator of a costimulatory signal involved in T-cell activation (costimulatory blocker).
-
-
Today, advanced treatment with highly active antiretroviral therapy (HAART) has pushed back the development of AIDS in many HIV-positive patients. Consequently, more people are living longer with HIV infection, increasing the likelihood that patients will present to the emergency department (ED) at some time during the course of their illness.
